Squamous cell carcinoma of the oral cavity

5 total trials 2 recruiting MedDRA PT

Filter these 5 trials by phase, country, sponsor and more.

Open in Search →

A Phase II, Open-Label, Single-Arm, Multicentre Study of Carboplatin, Paclitaxel, and Tislelizumab in Biomarker-Selected Patients with Resec … Pending

2024-517565-16-00 4 "Resectable Locally Advanced Oral Cavity Squamous Cell Carcin"
AFAN trial. Phase Ib/II study to investigate the safety and efficacy of Afatinib when administered as therapy in Fanconi anemia patients wit … Recruiting

2024-511477-29-00 4 2024-11-08 "Patients diagnosed with unresectable and / or metastatic loc"
Induction treatment of patients with head and neck squamous cell carcinoma using simultaneous chemotherapy and low-dose radiotherapy (iCHRTL … Recruiting

2024-517480-23-00 4 2022-02-17 "Head and neck squamous cell carcinoma"
Combined Pembrolizumab and Lenvatinib after definitive Chemoradiation of locally advanced HNSCC in PD-L1 positive patients (CPS≥1) Recruitment ended

2024-516536-10-00 4 2023-05-25 "Locally advanced head and neck squamous cell carcinoma"
Sentinel lymph node (SLN) detection in early oral cancer using Gallium-68-Tilmanocept PET/CT. Suspended

2025-521682-27-00 11 "Oral cancer"

Showing 1–5 of 5 trials